News

You can filter the posts based on tags:

Young talents honored at the DPLD Young Investigator Meeting

On November 16th and 17th, 2023, the DPLD Young Investigator Meeting took place at the DZL site in Heidelberg. The latest scientific findings in the field of Interstitial Lung Diseases were exchanged, and young investigators were honored.

2023-11-27

DZL Academy Symposium - Young Scientists Gather in Berlin

"When regeneration goes berserk: challenges and strategies in lung remodeling" was the theme of the DZL Academy Symposium 2023, which brought together 80 young scientists from November 22nd to 24th in Berlin.

2023-11-14

New insights into potential therapeutic approaches for COPD

Chronic obstructive pulmonary disease (COPD) is considered an incurable condition worldwide and one of the leading causes of death. Researchers from the ILH have now presented groundbreaking findings that offer a promising approach for the therapy of COPD.

2023-11-03

Autoantibodies discovered as potential biomarkers in idiopathic pulmonary fibrosis

Scientists at the DZL/ILH sites in Munich and Hanover have discovered that newly discovered autoantibodies help to better assess the course of idiopathic pulmonary fibrosis.

2023-10-10

Macrophages as a therapeutic key for lung cancer

Lung cancer is considered the most frequently lethal tumor disease. ILH scientists have shown that the reprogramming of a specific group of white blood cells, known as tumor-associated macrophages, could be a promising approach for cancer therapy.

2023-10-05

Pulmonary hypertension: Molecular investigation of the remodelling processes in the heart

ILH scientist Prof. Dr. Soni Savai Pullamsetti and her team have discovered signalling pathways involved in developing right heart failure in patients with pulmonary hypertension. The findings provide new biomarkers for diagnosis and targets for future therapies.

2023-10-04

How the lungs defend themselves against bacteria

A group led by Marburg-based ILH/DZL researcher Professor Dr Bernd Schmeck has studied how the respiratory tract reacts to infection with pneumococci, the most important pathogen causing pneumonia.

2023-09-30

Previously unknown cause for the development of pulmonary fibrosis discovered

Researchers have discovered a mechanism that promotes the development of pulmonary fibrosis. An innovative therapeutic approach based on this discovery showed promising results in a preclinical study.

« Previous 1 … 5 6 7 8 9 10 Next »

2023-10-04

How the lungs defend themselves against bacteria

A group led by Marburg-based ILH/DZL researcher Professor Dr Bernd Schmeck has studied how the respiratory tract reacts to infection with pneumococci, the most important pathogen causing pneumonia.

2023-09-30

Previously unknown cause for the development of pulmonary fibrosis discovered

2023-09-27

Institute for Lung Health gets a home

A new building for the Institute for Lung Health (ILH) is being constructed at the DZL site in Gießen, Marburg, Bad Nauheim.

2023-09-27

Prof. Soni Savai Pullamsetti, a new member of the Leopoldina

The National Academy of Sciences Leopoldina is Germany's oldest scientific and medical-learned society. ILH researcher Prof. Pullamsetti was admitted to the prestigious Leopoldina.

2023-09-25

New treatment approach for pulmonary hypertension: slowing harmful remodeling processes in the heart

ILH researchers have found that inhibiting a signaling pathway reduces pathological remodeling of the right ventricle in pulmonary hypertension.

2023-09-21

Develop antifibrotic drugs faster

In combination with single-cell technology, human tissue models will accelerate the translation of new antifibrotic agents in the future.

2023-07-06

Rajkumar Savai receives the „Mid-Career Achievement Award“ of the American Thoracic Society (ATS)

Professor Rajkumar Savai, MD, was awarded the Thoracic Oncology “Mid-Career Achievement Award” for his significant and meaningful contribution to thoracic oncology research at the 2023 Annual Meeting of the American Thoracic Society (ATS) International Conference in Washington, DC, USA.

2023-06-12

Why most smokers do not get COPD

An enzyme in alveoli cells protects most smokers from chronic obstructive pulmonary disease (COPD).

2023-06-08

First Integrated Single-Cell Atlas of the Human Lung

DZL/ILH researchers at Helmholtz Munich and their collaborators developed the Human Lung Cell Atlas using artificial intelligence (AI)-based techniques. This atlas elucidates the diversity of single lung cell types and allows learning about lung biology in health and disease.

« Previous 1 … 5 6 7 8 9 Next »

Archives